Cargando…
Pterostilbene on Metabolic Parameters: A Randomized, Double-Blind, and Placebo-Controlled Trial
Introduction. The purpose of this trial was to evaluate the effect of pterostilbene on metabolic parameters. Methods. A prospective, randomized, double-blind, and placebo-controlled study that enrolled 80 patients with a total cholesterol ≥200 mg/dL and/or LDL ≥ 100 mg/dL. Subjects were divided into...
Autores principales: | Riche, Daniel M., Riche, Krista D., Blackshear, Chad T., McEwen, Corey L., Sherman, Justin J., Wofford, Marion R., Griswold, Michael E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099343/ https://www.ncbi.nlm.nih.gov/pubmed/25057276 http://dx.doi.org/10.1155/2014/459165 |
Ejemplares similares
-
Analysis of Safety from a Human Clinical Trial with Pterostilbene
por: Riche, Daniel M., et al.
Publicado: (2013) -
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
por: Dellinger, Ryan W., et al.
Publicado: (2017) -
Impact of vitamin D status on statin-induced myopathy
por: Riche, Krista D., et al.
Publicado: (2016) -
Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
por: Dellinger, Ryan W., et al.
Publicado: (2018) -
Nicotinamide riboside with pterostilbene (NRPT) increases NAD(+) in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI
por: Simic, Petra, et al.
Publicado: (2020)